InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001576280-25-000181 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-06-16 2025-06-12+ GH POTTER MYRTLE S Dir M - OptEx $0.00 +6,743 20.7K +48% $0
D 2025-06-16 2025-06-16 GH POTTER MYRTLE S Dir S - Sale+OE $49.70 -2,626 18.2K -13% -$130.5K
DM 2025-06-16 2025-06-12+ GH POTTER MYRTLE S Dir M - OptEx $0.00 -6,743 274 -96% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-15 M A 69 $0.00 20,806 D — —
2 Common Common Stock 2025-06-16 S D 2,626 $49.70 18,180 D — —
3 Common Common Stock 2025-06-12 M A 6,674 $0.00 20,737 D — —
4 Derivative Restricted Stock Units 2025-06-12 M D 6,674 $0.00 0 D $0.00 · — to — 6,674 Common Stock (F1) The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. (F2) Not applicable for Restricted Stock Units.
5 Derivative Restricted Stock Units 2025-06-15 M D 69 $0.00 274 D $0.00 · — to — 69 Common Stock (F3) The restricted stock unit vested 25% of the shares subject to such award on October 15, 2022. The remaining 75% of the shares subject to such award vests in substantially equal installments on each monthly anniversary of October 15, 2022 during the three-year period thereafter. (F2) Not applicable for Restricted Stock Units.